Position in GLSI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$507,205
+$379,466 QoQ
Shares Held
21,116
+247.3% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. GLSI ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in GLSI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $507,205 | 21,116 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $127,739 | 6,080 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $40,854 | 4,106 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,734 | 1,845 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,489 | 3,196 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $73,634 | 6,557 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,336 | 2,807 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,188 | 1,807 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,015 | 402 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $19,356 | 1,840 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8 | 1 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,198 | 228 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13 | 1 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,004 | 724 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $16,461 | 1,809 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,368 | 870 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $16,186 | 825 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $67,247 | 2,764 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $168,391 | 4,310 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $34,154 | 760 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $10,533 | 309 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $32,093 | 880 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,274 | 277 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||